NCT05728619 2023-09-28
HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer
Shanghai Huilun Pharmaceutical Co., Ltd.
Phase 1/2 Unknown
Clinical Trials
13 trialsNCT04077866 2022-12-28
B7-H3 CAR-T for Recurrent or Refractory Glioblastoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1/2 Unknown
NCT05663125 2022-12-23
LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
Beijing Tiantan Hospital
Phase 1/2 Unknown
NCT02446704 2022-02-07
Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy
Massachusetts General Hospital
Phase 1/2 Unknown
NCT04547621 2020-09-14
HSCK-010
Huashan Hospital
Phase 1/2 Unknown
NCT04388033 2020-06-09
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1/2 Unknown
NCT00275067 2020-02-25
Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
Northwestern University
Phase 1/2 Unknown
NCT03607643 2018-07-31
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
Leaf Vertical Inc.
Phase 1/2 Unknown
NCT00014105 2013-12-04
Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT01181193 2011-03-29
Vitamin D for Treatment of Glioblastoma Multiforme
Soroka University Medical Center
Phase 1/2 Unknown
NCT00811759 2010-10-07
Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00394628 2007-05-30
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Novacea
Phase 1/2 Unknown
NCT00311857 2006-09-08
Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)
Heidelberg University
Phase 1/2 Unknown